Credit Rating- Revision

Poly Medi Limited o Regd.%fficeiazlggrggoonlgl:\:a ::duslvial Estate, ' ’ | POLYMED Phase-lll, New Delhi- 110 020 (INDIA) T: +91-11- 33550700, 47317000 E: info@polymedicure.com W: polymedicure.com CIN: L 40300DL1995PLC066923 26.06.2026 Scrip Code: - 531768 Scrip Code:- POLYMED The Manager, The Manager BSE Limited, National Stock Exchange of India Limited Department of Corporate Services, Exchange Plaza, Plot No. C/1-Block-G Phirozee Jeejeebhoy Towers, Bandra Kurla Complex, Bandra(E), Dalal Street, Mumbai- 400001. Mumbai-400051. Subject: - Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Disclosure of Credit Rating(s) assigned/re-affirmed by CRISIL Ratings Limited Dear Sir/Madam, In terms of Regulation 30 read with Para A of Part A of Schedule IIT of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that CRISIL Ratings Limited vide its letter dated 25t June, 2026 has revised the Long Term Rating Outlook as “Positive’ from ‘Stable’; Rating Reaffirmed and Reaffirmed the Short term Rating at Crisil A1+ . The credit rating assigned to the Company, as under: Total Bank Loan | Rs.500 Crore (Enhanced from Rs. 400 Crore) Facilities Rated Long Term Rating | Crisil AA-/Positive (Outlook revised from ‘Stable’; Rating Reaffirmed Short Term Rating | Crisil A1+ (Reaffirmed) For further details, a copy of Instrument Details for Credit Rating issued by CRISIL is enclosed herewith. The above information is available on the website of the Company at www.polymedicure.com This is for your information and record. For Poly Medicure Limited Avinash Chandra Company Secretary M. No. A32270 Enclosed:- As above Plants : Plot No.104-105 & 115-116-117, Sector-59, HSIIDC Industrial Area, Ballabgarh, Faridabad - 121004, Haryana (INDIA) Plot No. 33-34, Sector-68, IMT, Faridabad-121004, (Haryana) INDIA T: +91-129-4287000, 3355070 G Scanned with OKEN Scanner Crisil CONFIDENTIAL Ratings RL/POLML/398158/BLR/0626/151167 June 25, 2026 Mr. Naresh Vijayvergiya Chief Financial Officer Poly Medicure Limited Plotno 115, 116 Sector 59, Faridabad Faridabad - 121004 9873917171 Dear Mr. Naresh Vijayvergiya, Re: Review of Crisil Ratings on the bank facilities of Poly Medicure Limited All ratings assigned by Crisil Ratings are kept under continuous surveillance and review. Please find in the table below the ratings outstanding for the debt instruments/facilities of the company, and the rating actions by Crisil Ratings on the ratings as on date. Total Bank Loan Facilities Rated Rs.500 Crore (Enhanced from Rs.400 Crore) Long Term Rating Crisil AA-/Positive (Outlook revised from 'Stable'; Rating Reaffirmed) Short Term Rating Crisil A1+ (Reaffirmed) (Bank-wise details as per Annexure 1) As per our Rating Agreement, Crisil Ratings would disseminate the ratings, along with the outlook, through its publications and other media, and keep the ratings, along with the outlook, under surveillance over the life of the instrument/facility. Crisil Ratings reserves the right to withdraw, or revise the ratings, along with the outlook, at any time, on the basis of new information, or unavailability of information, or other circumstances which Crisil Ratings believes may have an impact on the ratings. Please visit www.crisilratings.com and search with the name of the rated entity to access the latest rating/s. In the event of the company not availing the proposed facilities within a period of 180 days from the date of this letter, a fresh letter of revalidation from Crisil Ratings will be necessary. Crisil Ratings products / activities or ratings of instruments other than securities that are listed or proposed to be listed may fall under the purview of financial sector regulators (FSRs) other than SEBI. In respect of such products / activities or ratings (under the purview of other FSRs such as Reserve Bank of India (RBI), Ministry of Corporate Affairs (MCA). Insurance Regulatory and Development Authority of India (IRDAI), among others), the grievance / dispute redressal and investor protection mechanisms available under SEBI regulations shall not be applicable. A list of products/activities or ratings of instruments falling under the purview of various FSRs along with the names of respective FSRs has been duly disclosed by Crisil Ratings on its website. A link to the same has been provided below for ready reference: https://www.crisilratings.conv/en/home/our-business/ratings/regulatory-disclosures/list-of-activities-instruments-and- names-of-regulators.html This letter will remain valid till March 31, 2027. After this date, please insist for a new rating letter (dated later than MGF 31, 2027). | Should you require any clarification, please feel free to get in touch with us. ‘With warm regards, Yours sincerely, Disclaimer. A rafing by Crisil Rafings reflects Crisil Rafings’ current opinion on fhe likeliood of fimely payment of the obiigafions under the rafed instrument, and does not constitute an audt of the rated entity by Crisil Ratings. Our ratings are based on information provided by the issuer or obtained by Crisil Ratings from sources it considers reliable. Crisil Ratings does not guarantee the completeness or accuracy of the information on which the: rating is based. A rating by Crisil Ratings is not a recommendation to bu/y se ll or hold the rated instrument; it does not comment on the market price or suitabiliy fora particular investor. Crisil Ratings has a practice of keeping all its ratings under surveillance and ratings are revised as and when circumstances so warrant. Crisil Ratings is not responsible for any errors and especially states that it has no financial liability whatsoever to the subscribers / users / ransmitters / distributors of its ratings. Crisil Ratings’ criteria are available without charge to the public on the web site, www crisilatings com. Crisil Ratings or its associates may have other commercial transactions with the company/entity. For the latest rating information on_any_instrument of any company rated by Crisil Ratings, please visit wwwcrisilratingscom or confact Customer Service Helpdesk at Crisiratingdesk@crisil.com or at 1800-267-3850 Crisil Ratings Limited Corporate Identity Number: U67100MH2019PLC326247 Registered Office: Lightbridge IT Park, Saki Vihar Road, Andheri East, Mumbai 400 072, India. e Phone: +91 22 6137 3000 | www.crisilratings.com acompany of S&P Global Crisil Ratings S >3 Gaurav Arora Nivedita Shibu Associate Director - Crisil Ratings Director - Crisil Ratings Annexure 1 - Bank-wise details of various facility classes (outstanding facilities) S.No. | Bank Facility Bank Amount (Rs. | 5 ¢ctanding Rating in Crore) 1 Fund-Based Facilities State Bank of India 2255 Crisil AA-/Positive e The Hongkong and Shanghai e - 2 Fund-Based Facilities Banking Corporation ]d uitted 10 Crisil AA-/Positive 3 | Fund-Based Faci HDFC Bank Limited 12.5 Crisil AA-/Positive 4 Fund-Based Facilities Citibank N. A. 16 Crisil AA-/Positive 5 Non-Fund Based Limit State Bank of India 100 Crisil A1+ 6__| Non-Fund Based Limit Citibank N. A. 9 Crisil A1+ 7 Non-Fund Based Limit State Bank of India 76.5 Crisil A1+ g | ProposedWorkmpCapitall | _ 505 Crisil AA-/Positive Facility Total 500 Disclaimer. A rafing by Crisil Rafings reflects Crisil Rafings’ current opinion on fhe likeliood of fimely payment of the obiigafions under the rafed instrument, and does not constitute an audt of the rated entity by Crisil Ratings. Our ratings are based on information provided by the issuer or obtained by Crisil Ratings from sources it considers reliable. Crisil Ratings does not guarantee the completeness or accuracy of the information on which the: rating is based. A rating by Crisil Ratings is not a recommendation to bu/y se ll or hold the rated instrument; it does not comment on the market price or suitabiliy fora particular investor. [Showing first 8,000 characters — download PDF for full document]